| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Henderson Jeffrey William is a Director at HALOZYME THERAPEUTICS, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 20,000 | $48.11 | $962,200.00 | -18.5% | -31.0% | -16.4% | |
| Feb 23, 2023 | QCOM Qualcomm Inc/de | Director | Sell | 5,000 | $124.12 | $620,600.75 | -42.7% | -18.4% | +22.7% | |
| Nov 25, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 24,498 | $40.08 | $981,757.35 | -34.0% | - | - | |
| Nov 10, 2020 | QCOM Qualcomm Inc/de | Director | Sell | 6,000 | $141.10 | $846,602.40 | -83.2% | - | - |